Cargando…

Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis

BACKGROUND: Liquid biopsy is a novel method for cancer diagnosis, which has been applied in lung and breast cancers, demonstrating high diagnostic value. However, clinical value of it in pancreatic cancer (PC) remains to be verified. The aim of this meta-analysis was to evaluate overall diagnostic v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuzhou, Zhang, Hao, Chen, Nan, Hao, Jianqi, Jin, Hongyu, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220382/
https://www.ncbi.nlm.nih.gov/pubmed/32011436
http://dx.doi.org/10.1097/MD.0000000000018581
_version_ 1783533148823355392
author Zhu, Yuzhou
Zhang, Hao
Chen, Nan
Hao, Jianqi
Jin, Hongyu
Ma, Xuelei
author_facet Zhu, Yuzhou
Zhang, Hao
Chen, Nan
Hao, Jianqi
Jin, Hongyu
Ma, Xuelei
author_sort Zhu, Yuzhou
collection PubMed
description BACKGROUND: Liquid biopsy is a novel method for cancer diagnosis, which has been applied in lung and breast cancers, demonstrating high diagnostic value. However, clinical value of it in pancreatic cancer (PC) remains to be verified. The aim of this meta-analysis was to evaluate overall diagnostic value of various liquid biopsy methods (circulating tumor DNA, circulating tumor cells and exosomes) in detecting PC. METHODS: We comprehensively searched relevant studies in PubMed, Medline, Embase, and Web of Science without time limitation according to PRISMA. Data necessary for reconstructing a 2 × 2 table was calculated from the original articles. The methodological quality of included studies was evaluated by QUADAS-2. Statistical analysis including was performed by the software Meta-Disc version 1.4, and STATA 14.2. RESULTS: A total of 19 studies including 1872 individuals were included in this meta-analysis. In which, 7 were studies about ctDNA, 7 were on CTCs and 6 were about exosomes (Sefrioui D(1), studied diagnostic accuracy of both ctDNA and CTCs, with no common patients in these 2 groups). The pooled sensitivity estimates for ctDNA, CTCs and exosomes in detecting PC with their 95% confidential intervals (95% CI) were 0.64 (95%CI 0.58–0.70), 0.74 (95%CI 0.68–0.79) and 0.93 (95%CI 0.90–0.95), respectively. The pooled specificity estimates were 0.92(95%CI 0.88–0.95), 0.83 (95%CI 0.78–0.88) and 0.92 (95%CI 0.88–0.95), respectively. The area under curve (AUC) of the sROC for ctDNA, CTCs and exosomes in detecting PC were 0.9478, 0.8166, and 0.9819, respectively. The overall sensitivity, specificity and AUC of the sROC curve for overall liquid biopsy in detecting PC were 0.80 (95%CI 0.77–0.82), 0.89 (95%CI 0.87–0.91) and 0.9478, respectively. CONCLUSION: This meta-analysis confirmed that liquid biopsy had high diagnostic value in detecting PC. In ctDNA, CTCs and exosomes these 3 subgroups, exosomes showed highest sensitivity and specificity.
format Online
Article
Text
id pubmed-7220382
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72203822020-06-15 Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis Zhu, Yuzhou Zhang, Hao Chen, Nan Hao, Jianqi Jin, Hongyu Ma, Xuelei Medicine (Baltimore) 4100 BACKGROUND: Liquid biopsy is a novel method for cancer diagnosis, which has been applied in lung and breast cancers, demonstrating high diagnostic value. However, clinical value of it in pancreatic cancer (PC) remains to be verified. The aim of this meta-analysis was to evaluate overall diagnostic value of various liquid biopsy methods (circulating tumor DNA, circulating tumor cells and exosomes) in detecting PC. METHODS: We comprehensively searched relevant studies in PubMed, Medline, Embase, and Web of Science without time limitation according to PRISMA. Data necessary for reconstructing a 2 × 2 table was calculated from the original articles. The methodological quality of included studies was evaluated by QUADAS-2. Statistical analysis including was performed by the software Meta-Disc version 1.4, and STATA 14.2. RESULTS: A total of 19 studies including 1872 individuals were included in this meta-analysis. In which, 7 were studies about ctDNA, 7 were on CTCs and 6 were about exosomes (Sefrioui D(1), studied diagnostic accuracy of both ctDNA and CTCs, with no common patients in these 2 groups). The pooled sensitivity estimates for ctDNA, CTCs and exosomes in detecting PC with their 95% confidential intervals (95% CI) were 0.64 (95%CI 0.58–0.70), 0.74 (95%CI 0.68–0.79) and 0.93 (95%CI 0.90–0.95), respectively. The pooled specificity estimates were 0.92(95%CI 0.88–0.95), 0.83 (95%CI 0.78–0.88) and 0.92 (95%CI 0.88–0.95), respectively. The area under curve (AUC) of the sROC for ctDNA, CTCs and exosomes in detecting PC were 0.9478, 0.8166, and 0.9819, respectively. The overall sensitivity, specificity and AUC of the sROC curve for overall liquid biopsy in detecting PC were 0.80 (95%CI 0.77–0.82), 0.89 (95%CI 0.87–0.91) and 0.9478, respectively. CONCLUSION: This meta-analysis confirmed that liquid biopsy had high diagnostic value in detecting PC. In ctDNA, CTCs and exosomes these 3 subgroups, exosomes showed highest sensitivity and specificity. Wolters Kluwer Health 2020-01-17 /pmc/articles/PMC7220382/ /pubmed/32011436 http://dx.doi.org/10.1097/MD.0000000000018581 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4100
Zhu, Yuzhou
Zhang, Hao
Chen, Nan
Hao, Jianqi
Jin, Hongyu
Ma, Xuelei
Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title_full Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title_fullStr Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title_full_unstemmed Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title_short Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis
title_sort diagnostic value of various liquid biopsy methods for pancreatic cancer: a systematic review and meta-analysis
topic 4100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220382/
https://www.ncbi.nlm.nih.gov/pubmed/32011436
http://dx.doi.org/10.1097/MD.0000000000018581
work_keys_str_mv AT zhuyuzhou diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis
AT zhanghao diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis
AT chennan diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis
AT haojianqi diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis
AT jinhongyu diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis
AT maxuelei diagnosticvalueofvariousliquidbiopsymethodsforpancreaticcancerasystematicreviewandmetaanalysis